Beyond the Pharmacy Counter: How Delayed Prescriptions Are Triggering Major Medical Claims

The prescription drug cost crisis in the United States has escalated from an individual financial strain into a systemic workforce and corporate liability. According to tracking data from KFF (Kaiser Family Foundation), roughly 43% of U.S. adults report not taking their medications as prescribed over the past year due to cost.

This isn’t just about minor inconveniences—it represents a massive breakdown in care adherence that directly hits employer bottom lines, productivity, and health plan claims.

The Anatomy of the Care Delay: What the Stats Reveal

When faced with steep prices at the pharmacy counter, employees resort to dangerous rationing tactics to stretch their household budgets. Research highlights the specific ways Americans skip or delay their prescription care:

• 31% take over-the-counter alternatives instead of filling a necessary prescription.
• 27% leave their prescriptions unfilled entirely at the pharmacy.
• 19% cut pills in half or skip doses to make a single fill last longer.

While lower-income workers are hit hardest, health insurance offers no guaranteed protection. A survey by the West Health-Gallup Center on Healthcare in America revealed that fewer than half of Americans (49%) are “Cost Secure,” meaning millions of full-time, insured employees regularly worry about affording their needed medications.

Why Employers and Brokers Must Solve This Problem

For brokers, HR leaders, and CFOs, delayed prescription care creates a cascading “domino effect” across the entire organization:

1. Minor Drug Cost Reduction Creates Major Medical Claims

When an employee skips a $50 maintenance medication for diabetes, high blood pressure, or asthma, the underlying condition doesn’t vanish, it worsens. KFF data shows that nearly 18% of adults report their health worsened explicitly because they delayed or skipped care due to cost. What could have been a low-cost pharmacy expense rapidly transforms into a $50,000 emergency room visit or inpatient hospitalization that lands squarely on the employer’s self-funded health plan.

2. The Productivity Tax

Unmanaged chronic illness directly translates to increased presenteeism (employees working while sick and unproductive) and extended absenteeism. When workers can’t afford their specialty or daily therapies, business operational efficiency suffers.

3. Fiduciary and Legal Risks Under the CAA

Under regulations like the Consolidated Appropriations Act (CAA), plan sponsors have an explicit fiduciary responsibility to manage health plan assets prudently and ensure vendors aren’t driving up costs through opaque contracts. Failing to offer a pharmacy model that guarantees affordable, accessible medications exposes company executives to legal liabilities.

The Takeaway for Plan Leadership

Delivering “coverage” on paper is no longer enough if employees cannot afford the care at the pharmacy counter. High out-of-pocket prescription costs are not an unmanageable law of nature; they are the direct outcome of traditional, rebate-driven Pharmacy Benefit Manager (PBM) contracts that inflate list prices to maximize intermediary margins.

To protect both employee health and corporate budgets, brokers and employers must shift from passive renewal strategies to active, unbundled procurement. By partnering with transparent sourcing models and advocacy solutions, plan sponsors can bypass traditional markup channels, lower out-of-pocket costs for critical medications, and ensure their workforce gets the care they need before a preventable issue turns into a critical health crisis.